Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay.

Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay.

Globally, malignant melanoma shows a steady increase in the incidence among cancer diseases. Malignant melanoma represents a cancer type where currently no biomarker or diagnostics is available to identify disease stage, progression of disease or personalized medicine treatment. The aim of this stud...

Full description

Bibliographic Details
Main Authors: Charlotte Welinder, Göran B Jönsson, Christian Ingvar, Lotta Lundgren, Bo Baldetorp, Håkan Olsson, Thomas Breslin, Melinda Rezeli, Bo Jansson, Thomas E Fehniger, Thomas Laurell, Elisabet Wieslander, Krzysztof Pawlowski, György Marko-Varga
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4204935?pdf=render

Internet

http://europepmc.org/articles/PMC4204935?pdf=render

Similar Items